- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06313775
Comparison of Spinal Anesthesia and Spermatic Cord Block for Bilateral Orchiectomy
The Feasibility of Local Anesthesia for Bilateral Orchiectomy : a Randomized Controlled Trial
The goal of this randomized controlled trial is to compare intraoperative pain score, Morphine consumption during 6 and 12 hour after surgery, and postoperative complications between SA and SCB groups in metastatic prostate cancer patient. The main question it aims to answer are:
• Is there a difference in the level of pain during bilateral orchiectomy between spinal anesthesia and spermatic cord block?
Participants will undergo bilateral orchidectomy. They will be randomly assigned to two groups: the group receiving spinal anesthesia and the group receiving spermatic cord block If there is a comparison group: Researchers will compare intraoperative pain score, Morphine consumption during 6 and 12 hour after surgery, and postoperative complications in both groups of patients.
Study Overview
Status
Intervention / Treatment
Detailed Description
Objective : To compare intraoperative pain score, Morphine consumption during 6 and 12 hour after surgery, and postoperative complications between SA and SCB groups.
Material and Method : This Randomized Controlled Trial that collected data from prostate cancer patients who underwent orchiectomy in our institution. Patients were randomly divided into two groups; SA and SCB. Data was collected on intraoperative pain score, 1 hour post-surgery, Morphine consumption during 6 and 12 hour after surgery and complications. All data was statistically analyzed using Independent t-test and Fisher's exact test.
Inclusion criteria : Patients of all ages diagnosed with prostate cancer undergoing treatment with bilateral orchiectomy.
Exclusion criteria :
- Patients with a history of Xylocaine allergy.
- Patients with uncorrected bleeding disorders.
- Patients with paralysis or neurosensory deficits
- Patients with dementia or cerebrovascular accidents (strokes) that impair communication.
Patients with contraindications for spinal anesthesia, including:
- Patient refusal of spinal anesthesia.
- Infection at the site of spinal injection.
- Allergy to specific types of local anesthetics, such as Hyperbaric bupivacaine.
- Inability of the patient to cooperate with the spinal anesthetic procedure.
- Suspicion of high intracranial pressure based on abnormal physical examination.
- Aortic stenosis with fixed cardiac output.
- Low platelet count.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Ubon Ratchathani, Thailand, 33000
- Sanpasitthiprasong Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients of all ages diagnosed with prostate cancer undergoing treatment with bilateral orchiectomy
Exclusion Criteria:
- Patients with a history of Xylocaine allergy.
- Patients with uncorrected bleeding disorders.
- Patients with paralysis or neurosensory deficits
- Patients with dementia or cerebrovascular accidents (strokes) that impair communication.
Patients with contraindications for epidural anesthesia, including:
- Patient refusal of spinal anesthesia.
- Infection at the site of spinal injection.
- Allergy to specific types of local anesthetics, such as Hyperbaric bupivacaine.
- Inability of the patient to cooperate with the spinal anethetic procedure.
- Suspicion of high intracranial pressure based on abnormal physical examination.
- Aortic stenosis with fixed cardiac output.
- Low platelet count.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Spinal anesthesia
spinal anesthesia : 0.5%hyperbaric bupivacaine 10-15 mg/dose injected at L3-L5
|
Bilateral simple orchiectomy is the surgical removal of both testicles through an incision in the scrotum.
|
Experimental: spermatic cord block
1%Xylocaine with adrenaline (Max 7 mg/kg/dose) divided to inject into each side of the spermatic cord 6-8 ml and infiltration into the scrotal incision area 3-4 ml.
|
Bilateral simple orchiectomy is the surgical removal of both testicles through an incision in the scrotum.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
intraoperative pain score
Time Frame: Immediate postoperative assessment
|
Pain assessment is done using the verbal numerical rating scale, where patients rate their pain level from 0 to 10, with 0 indicating no pain and 10 indicating the worst pain imaginable, without using any materials or equipment.
|
Immediate postoperative assessment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
post-operative pain score
Time Frame: 1 hour after surgery
|
Pain assessment is done using the verbal numerical rating scale, where patients rate their pain level from 0 to 10, with 0 indicating no pain and 10 indicating the worst pain imaginable, without using any materials or equipment.
|
1 hour after surgery
|
morphine consumption
Time Frame: during 6 and 12 hour after surgery
|
Morphine consumption after surgery
|
during 6 and 12 hour after surgery
|
post-operative complications
Time Frame: 24 hour after surgery
|
Postoperative complications assessment such as acute urinary retention and neurological complications like radiculopathy, neurological deficits, cauda equina syndrome, and paraplegia.
|
24 hour after surgery
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Thararat Wanthawong, MD, Sanpasitthiprasong Hospital
- Principal Investigator: Wattanachai Ungjaroenwathana, MD, Sanpasitthiprasong Hospital
- Principal Investigator: Sahachart Atichosakun, MD, Sanpasitthiprasong Hospital
- Principal Investigator: Rawisara Hongkrisadakorn, MD, Sanpasitthiprasong Hospital
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- SPS005
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Prostate Cancer
-
Roswell Park Cancer InstituteRecruitingObesity | Overweight | Cancer Survivor | Prostate Adenocarcinoma | Stage I Prostate Cancer | Stage II Prostate Cancer | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate Cancer | Stage IVA Prostate Cancer | Stage IVB Prostate Cancer | Stage A Prostate Cancer | Stage... and other conditionsUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Regeneron Pharmaceuticals; Prostate Cancer FoundationWithdrawnStage III Prostate Cancer | Stage IV Prostate Cancer | Stage IVA Prostate Cancer | Stage IVB Prostate Cancer | Stage IIIA Prostate Cancer | Stage IIIB Prostate Cancer | Stage IIIC Prostate Cancer
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Ryan Kohlbrenner, MDRadiological Society of North AmericaCompletedProstate Adenocarcinoma | Stage IV Prostate Cancer AJCC v8 | Prostate Carcinoma | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage...United States
-
Jonsson Comprehensive Cancer CenterProgenics Pharmaceuticals, Inc.TerminatedRandomized Trial of PSMA PET Scan Before Definitive Radiation Therapy for Prostate Cancer (PSMA-dRT)Stage II Prostate Cancer AJCC v8 | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IIA Prostate Cancer AJCC v8 | Stage IIB Prostate Cancer AJCC v8 | Stage I Prostate...United States
-
University of Southern CaliforniaNational Cancer Institute (NCI); SanofiTerminatedDiarrhea | Recurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Ohio State University Comprehensive Cancer CenterRiverside Methodist HospitalCompletedStage I Prostate Cancer | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Mayo ClinicNational Cancer Institute (NCI)WithdrawnStage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8 | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IIA Prostate Cancer AJCC v8 | Stage IIB Prostate...United States
-
Barbara Ann Karmanos Cancer InstituteGenentech, Inc.CompletedRecurrent Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
University of California, IrvineCompletedRecurrent Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
Clinical Trials on bilateral orchiectomy
-
Chang Gung Memorial HospitalCompletedOverall Survival RatesTaiwan
-
Odense University HospitalAarhus University Hospital; University of CopenhagenCompleted
-
Mayo ClinicCompletedContraceptionUnited States
-
St. Joseph's Hospital and Medical Center, PhoenixTerminatedParkinson's Disease | Dementia | Mild Cognitive ImpairmentUnited States
-
Herlev HospitalCompletedFatty Liver | Metabolic Syndrome | Prostate Cancer | HypogonadismDenmark
-
National Institute on Deafness and Other Communication...Terminated
-
University Hospital TuebingenUnknown
-
Bambino Gesù Hospital and Research InstituteRecruiting
-
European Organisation for Research and Treatment...Completed
-
Bezmialem Vakif UniversityUnknownArthroplasty Complications | Joint Infection | Infection JointTurkey